BaiYiYuan Biotech
Next-generation regenerative biomaterials, leveraging SIS-ECM technology to advance tissue repair and aesthetic medicine.
Employees
Enterprise value
$11—17m
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY20.0m | Late VC | |
| Total Funding | 000k | ||
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads